Changes in metabolic homeostasis in pregnant diabetic women are potential determinants of increased adiposity of the fetus. The aim of this study was to characterize diabetes mellitus-induced changes in genes for fetoplacental energy metabolism in relation to fetal adiposity.
D
iabetic macrosomia results from modification of body composition with increased adiposity at birth rather than changes in lean mass. 1 How maternal diabetes mellitus translates into enhanced lipid deposition in adipose tissue of the fetus is not understood currently. The association between high maternal glucose levels and increased birthweight has long been documented in diabetic pregnancy. 2 However, fetal macrosomia is also observed in diabetic pregnancy with satisfactory glycemic control [3] [4] [5] and in offspring of obese women with normal glucose tolerance and only mild or no hyperglycemia, [6] [7] [8] which suggests that either modest variation in fetal glycemia or in energy substrates other than glucose contribute to the enhancement of fat deposition in fetal adipose tissue. Based on the dogma of adipocyte biology, enhanced adipogenesis relies on a plethora of adipogenic substrates in association with a hyperinsulinic milieu. The availability of fetal energy substrates is regulated in the first place by their maternal circulating concentrations and to the extent that they are transported across the placenta. Hence, the hyperglycemia and hypertriglyceridemia that are facilitated by the insulin resistance of the diabetic mothers are potential factors to enhance substrate availability to the fetus. [9] [10] [11] The structural and functional characteristics of the trophoblast cells allow flexibility in glucose uptake, metabolism, and transfer to adapt to concentration changes. 12 Maternal free fatty acids (FFAs) are also taken up by placental cells for direct fetal transfer to the fetus. 13 However, complex lipids, such as triglycerides, can be transported only after hydrolysis by specific trophoblast lipases. 14 The subsequent reesterification of FFA suggests that interim storage takes place within the placenta, as suggested in the rodent model of diabetes mellitus. 15 However, there is only scant information to assess the regulation of placental-fetal lipid fluxes in pregnancy with abnormal lipid homeostasis. 16 In a first step toward the characterization of the mechanisms that regulate fetal adipogenic capacity, we have characterized the changes in placental glucose and lipid pathways that are induced by diabetes mellitus. To encompass an array of diabetic diseases and neonatal outcomes, we have included pregnancies with type 1 diabetes mellitus (T1DM) and gestational diabetes mellitus (GDM), which is a milder diabetic pathologic condition that is similar in many respects to type 2 diabetes mellitus. 17 In this article, we show that diabetes mellitus induces major alterations of key pathways for fetoplacental lipid fluxes with differential activation in GDM and T1DM.
MATERIALS AND METHODS

Study subjects
The protocol was approved by the institutional review boards of MetroHealth Medical Center and Hôpital Cochin; volunteers gave informed written consent in accordance with each institution's guidelines. Women with no pregnancy complication (n ϭ 5), GDM (n ϭ 9), or T1DM (n ϭ 6) were recruited at the time of delivery in term pregnancy. GDM was defined as an abnormal glucose tolerance during the third trimester, according to the criteria defined by Carpenter and Coustan. 18 All women with GDM required insulin therapy for glucose control. Glycemic control for the diabetic women was considered satisfactory based on an average percentage of hemoglobin A 1C Ͻ 6.3 (Table 1) . Placenta, maternal, and cord blood samples were obtained at the time of term elective cesarean section delivery. Maternal anthropometrics were recorded at the first antenatal visit. At term, women with T1DM were hyperglycemic and hyperinsulinemic. No significant hyperlipidemia was noted in mothers or fetuses, although there was a tendency to slightly higher plasma nonesterified fatty acids in women with GDM. Neonatal anthropometric measurements were performed at delivery. Fetuses of both women with GDM and with T1DM were hyperinsulinemic and macrosomic, with increased adiposity at birth, based on higher ponderal index (Table 1) .
Analysis of glucose, lipids, and insulin
Plasma glucose was measured by the glucose oxidase method with a glucose analyzer (Yellow Springs Instrument, Yellow Springs, OH). Plasma FFA concentrations were determined with an enzymatic method (WAKO Chemicals, Neuss, Germany). Plasma triglyceride concentrations were determined with an enzymatic method (Sigma Chemical Company, St. Louis, MO). Plasma insulin was assayed by radioimmunoassay (Linco, St. Louis, MO).
Tissue and microarray processing
For each placenta, 6 biopsies (approximately 1 cm 3 ) were sampled within 5 distinct cotyledons (30 fragments total) after the basal and the chorial plates were dissected out and were snap frozen in liquid nitrogen. Total RNA was prepared from 12 of 30 randomly selected tissue samples with CsCl gradient 19 and electrophoresed to verify integrity. Aliquots of the 12 RNA samples that were prepared from each placenta were pooled and reverse transcribed into complementary DNA with Superscript firststrand synthesis (Invitrogen, Carlsbad, CA). The pooling strategy was used to minimize inter-and intraplacenta structural variations that are inherent to human placental heterogeneity. Biotinylated complementary RNA was generated by in vitro transcription (ENZO Kit; Affymetrix, Santa Clara, CA) and evaluated 
Data analysis
Selection of the significantly modified transcripts was performed by the application of the following filter strategy: all probe sets with an intensity signal below the probe pair threshold were excluded. Among the genes that showed an absolute call of present according to MAS 5.0 algorithm, we selected the genes with a difference in signal detection of at least 4.5 times the average background, minus the scaled noise. The genes that satisfied these criteria were then selected on the basis of a fold change Ն 1.52 or Յ Ϫ1.52 that was consistent in at least 2 comparisons. The genes that did not meet the fold change criteria were referred to as "not significantly changed." Genes that were related to glucose and lipid metabolism were identified according to the function of their putative encoded proteins from public databases. Fold changes were validated by real-time polymerase chain reaction measurements on 10 selected genes ( Table 2 ). The hybridization intensities of significantly modified genes were examined by hierarchic cluster analysis with GeneSpring GX software (Agilent Technologies, Inc, Santa Clara, CA) and Treeview software (free).
Isolation of primary placental cells, culture, and immunofluorescence
Placental cells were isolated through sequential DNase digestion and Percoll gradient (Amersham Pharmacia Biotech, Piscataway, NJ) centrifugation, as previously described. 20 Approximately 30-45 g of villous tissue was dissected within 10 minutes of delivery, blotted on sterile gauze, and washed with saline solution to remove excess blood. The tissue was then digested 3 times at 37°C in a shaking water bath for 30 minutes each with 0.25% trypsin and 300 U/mL DNase I in Hanks' balanced salt solution, pH 7.4. Cytotrophoblasts were separated from mononuclear cells by Percoll gradient centrifugation. Cells were counted and seeded in Iscove medium supplemented with 10% fetal calf serum in 12-well plates at a density of 2.5 ϫ 10 6 cells per well.
Cell culture and placental lipid analysis
After overnight incubation, nonadherent cells were washed twice with serum-free standard DMEM medium. Cells were cultured with serum-free DMEM medium that contained 5.5 mmol/L glucose and 0.15 mmol/L bovine serum albumin (control; Sigma Chemical Company) or supplemented with 10 mmol/L glucose or 400 nmol/L oleic acid complexed to bovine serum albumin for 48 hours. For RNA extraction, cells were lysed with 0.5 mL Trizol per well. For lipid staining, cells were washed with phosphate-buffered saline solution and then fixed in 4% paraformaldehyde for 30 minutes at room temperature. Cells were exposed for 30 minutes to BODIPY 493/503 (Molecular Probes; Invitrogen). Nuclei were counterstained with DAPI (Millipore, Billerica, MA). Slides were mounted in permanent aqueous mounting medium (DAKO Corp, Carpinteria, CA) and viewed with a confocal laser scanning microscope (model LSM Meta 510; Zeiss, Jena, The signal intensities were obtained after normalization with MAS 5.0 microarray suite software (Affymetrix, Santa Clara, CA). Numbers in parentheses show fold changes between diabetic and control groups that were estimated by real-time polymerase chain reaction. Fold changes between diabetic and control groups were significant at a probability value of Ͻ .005. GDM, gestational diabetes mellitus; nsc, not significantly changed; T1DM, type 1 diabetes mellitus.
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Germany); nuclei were counted manually from 6 random fields per slide, with 15 nuclei per field. Lipid droplets were counted and quantified from digital images with the use of MetaMorph imaging software (Molecular Devices, Downingtown, PA). Each experiment was performed in duplicate.
Real-time polymerase chain reaction
Expression of stearoyl CoA desaturase (SCD), 3-hydroxy-methylglutaryl-CoA reductase (HMGCR), and 3-hydroxymethylglutaryl-CoA synthase 1 (HMGCS) was quantified by real-time reverse transcriptase-polymerase chain reaction (Lightcycler; Roche Molecular Diagnosis, Indianapolis, IN) in primary cultured trophoblast cells that had been incubated with glucose and oleate. Results were normalized for beta-actin: SCD primers: forward: TGTGTCCCAGATGCTGTCAT, reverse: CCCACCCAATCACAGAAAAG (Genebank accession number NM_005063). HMGCR primers: forward: TGTTTCA-GATTGCAAGGTAATATGT, reverse: CCTGGCACCCAAAAGTTAAA (Genebank accession number NM_000859). HMGCS primers: forward: TTAGCTT-TCTCAGGGGGTCA, reverse: CCATG-GTTTCCTGGAATGTT (Genebank accession number NM_002130).
Statistical analysis
Data are presented as mean Ϯ SEM.
Comparisons between groups were performed with 1-way analysis of variance. Significance for statistical differences was calculated with a 2-tailed Student t test for unpaired data. Differences were considered significant with a probability value of Ͻ .05.
RESULTS
Clusters for metabolic genes in placenta of GDM and T1DM
Hierarchical cluster analysis showed enhancement of lipid pathways in both GDM and T1DM (Figure 1) . Among the 49 genes that were related to lipid and glucose energy pathways that were significantly modified, 45 genes were upregulated, and 4 genes were downregulated. Four distinct categories of genes were identified based on the functional property of their putative encoded proteins: (1) lipid transport and activation, (2) lipid metabolism, (3) glycogen metabolism, and (4) hexosamine pathways ( Table 2 ). Most of the activated genes (67%) were implicated in lipid pathways, and only 9% of the activated genes were related to glucose energy metabolism, with a clear dichotomy between T1DM and GDM. Genes at key steps of fatty acid uptake, transport, and activation pathways were similarly upregulated in pregnancy with GDM and T1DM (Table 2) . However, pathways for triglyceride and cholesterol biosynthesis were enhanced selectively in GDM and obesity. There were marked differences in clusters of glucose-related genes, with pathways for glycogen turnover that primarily were enhanced in GDM and hexosamine pathway and glycosylation reactions essentially recruited in T1DM ( Figure 1 and Table 2 ).
Genes for lipid transport and metabolism
The pattern of genes for fatty transport and activation showed similarities in GDM and T1DM. FABP4 and FABP5 (2 isoforms of the fatty acid binding proteins family for facilitated transport of FFA) were upregulated 2-fold compared with control (Figure 2, A) . The 3 isoforms of the fatty acylCoA ligases (FACL2,3,4) that catalyze the conversion of fatty acids into fatty acylCoA esters to serve as precursors for the synthesis of triglycerides, cholesterol, and membrane phospholipids were also activated. The endothelial lipase LIPG, which hydrolyzes complex lipids into FFA before they can be taken up by the placental cells, was also higher in diabetes mellitus ( Figure  2, B) . A robust activation of lipid metabolism that was observed essentially in GDM was supported by the upregulation of several genes in lipid biosynthetic pathways ( Figure 3 ). The 8-fold increase in SCD; an enzyme which introduces double bonds into growing fatty acid chains, indicated a recruitment of cellular pathways that leads to triglyceride synthesis. Activation of cholesterol synthesis and steroidogenesis was suggested by the coordinated upregulation of HMGCR, HMGCS 1, emopamil sterol isomerase, squalene epoxidase, and sterol 4 methyl oxidase. The link between the upregulation of lipid pathways and lipid storage capacity of placental cells was assessed in vitro under conditions of high glucose and lipid availability. The expression of SCD, HMGCS, and HMGCR was activated 1.5-to 2.7-fold (P Ͻ .001) by culture 
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Basic Science: Obstetrics Research of freshly isolated trophoblast cells in the presence of 400 nmol/L oleate but not with 10 mmol/L glucose ( Figure 4 ). The size of the lipid droplets was increased 4-fold (P Ͻ .002) with the addition of oleate and 1.9-fold (P Ͻ .05) with 10 mmol/L glucose in the culture medium ( Figure 5 ). The stimulatory effect of oleate was not further enhanced by glucose.
Genes for glucose metabolism
In contrast to the prominent activation of lipid pathways, genes that were related to glucose metabolism represented a smaller proportion (9% vs 67%) of the recruited genes. The activation of glycogen, the protein priming glycogen synthesis from uridine diphoshoglucoseglucose, the glycogen branching enzyme GBE1, and amylo1-6 glucosidase AGL indicated active glycogen turnover in GDM only (Table 2 and Figure 6 ). Ten genes (22% of diabetes mellitus-modified genes) that were involved in glycosylation, acylation processes, and the hexosamine synthetic pathway were recruited exclusively in the placenta of T1DM ( Table 2 ). The 5-fold activations of the fucosyltransferase FUT5 gene and the hyaluronoglucosaminidase HYAI4 gene were indicative of modifications in the carbohydrate content of glycoproteins.
COMMENT
The most significant findings of this study were that diabetes mellitus induced an overrepresentation of genes that were implicated in placental lipid pathways, compared with genes that were related to glucose metabolism. Furthermore, there was a clear dichotomy between GDM and T1DM as regards to lipid and glucose metabolism. Genes for transport and activation of fatty acids and low density lipoprotein were upregulated to similar extent in GDM and T1DM, which reflected the increased availability of lipid substrates at the maternal-placental interface. Pathways for intracellular lipid biosynthesis were selectively upregulated in pregnancy with GDM and obesity. The robust activation of SCD indicates an enhancement in the anabolic pathways that lead to the accumulation of triglycerides. High desaturase activities have also been associated with insulin resistance and dyslipidemia in obese rodents. 21 Fatty acid desaturases are rate-limiting enzymes for triglyceride synthesis that are highly sensitive to dietary changes. 22, 23 The ability of oleate to stimulate the expression of SCD and lipid droplet formation in vitro delineates fatty acids as lipogenic substrates, as previously suggested. 24 The enhanced expression of ADRP and SCP-2, which facilitate the storage of FFA and cholesterol into membrane and neutral lipids, further highlights that coordinated mechanisms are set to favor lipid accumulation in a diabetic environment. 25 Our data support the original hypotheses by Szabo and Szabo, 26 Shafrir and Khassis, 15 and Diamant et al 27 that the accumulation of placental triglycerides represents a regulatory step toward excess fetal adiposity. Additionally, our results emphasize that glucose plays only a minor role in triglyceride accumulation through de novo lipid synthesis in agreement with the absence of acetyl-CoA carboxylase and fatty acid synthase in placental cells. 28 The second lipid pathway that we found upregulated in GDM leads to cholesterol synthesis through activation of HMG-CoA reductase and HMG-CoA synthetase. This is further supported by the 2-and 12-fold upregulation of squalene epoxidase and emopamil binding protein, which catalyzes distal steps of cholesterol biosynthesis. 29 As primary constituents of cell membranes, phos- 
Changes in pathways for placental lipid transport in diabetes mellitus
The table shows fold changes of regulated genes that are related to lipid transport in gestational diabetes mellitus/type 1 diabetes mellitus. The schematic diagram shows the molecules that are related to placental lipid transport. The placental barrier is formed by the syncytiotrophoblast cells (yellow) that face the maternal side and the endothelial cells (red) that line the fetal vascular system. nsc, not significantly changed. A, The fatty acid binding proteins (FABPs) that are located on both sides of the syncytial cells bind fatty acids for import from the maternal circulation and export from the placenta to the fetal circulation. The fatty acyl-CoA ligases (FACLs) process the first step of fatty acid elongation toward esterification of free (nonesterified) fatty acids (NEFA) into triglycerides (TG). B, The lipases endothelial lipase (LIPG) and lipoprotein lipase (LPL) break down triglycerides (TG) and complex lipids before uptake by trophoblast cells or export to the fetal circulation. The phospholipase A2 (PLA2) contributes to mobilization of phospholipids.
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Research Basic Science: Obstetrics www.AJOG.org pholipids and cholesterol regulate membrane lipid composition and, consequently, changes in membrane fluidity. Phosphatidylcholine cytidyltransferase PCYT1B and sterol carrier protein SCP-2, which enhance the ratio of phospholipids/cholesterol, are associated classically with fluidization and altered functions of membrane proteins. 30 The phospholipid composition of the monolayer profoundly affects droplet morphologic condition and lipid use. 31 Hence, the molecular changes that were observed may result in higher membrane fluidity and ubiquitous lipid storage, which are 2 potential interim steps toward increased transplacental transfer of lipids.
Our overall concept is that maternal environmental factors contribute to the regulation of genes for lipid transport and metabolism in the placenta of women with GDM. Because maternal FFA and triglyceride plasma concentrations were not modified in lean type 1 diabetic or obese women with GDM, this raises the question of whether changes in maternal lipid fluxes contribute to the observed placental changes. Recent findings in a population of well-controlled GDM pregnancies in overweight women that showed that circulating maternal lipids, but not glucose, correlate with fetal growth provide strong support to this view. 32 Preliminary studies from our group indicate that obesity in pregnancy, without maternal hyperlipidemia, enhances the expression of similar placental lipid gene clusters (unpublished data). This raises the possibility that the environment of obesity may be critical for the regulation of placental lipid pathways. Whether an excess of 
Changes in placental lipid biosynthetic pathways in diabetes mellitus
Fold changes and schematic representation of selected genes in pathways that regulate the synthesis of triglycerides, cholesterol, and phospholipids in gestational diabetes mellitus/type 1 diabetes mellitus. 
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Basic Science: Obstetrics Research placental lipids are mobilized and exported into the fetal circulation is critical information for understanding the regulation of fetal adiposity that is not yet known with certainty. The positive maternofetal FFA concentration gradient in humans reflects FFA taken up by all fetal tissues, not only by adipose tissue. Hence, fetal FFA concentrations cannot be used as markers of fat deposition in utero. The upregulation of the lipid carriers FABP4 and FABP5 suggests an enhancement of placental fatty acid fluxes. The location of the FABPs on both sides of the bipolar syncytiotrophoblast cells may favor transport of free fatty acids in both directions (ie, from mother to fetus and vice versa). 33 Increased expression of the endothelial lipase LIPG2 provides additional evidence for the mobilization of lipids for export to the fetal circulation. 34, 35 Taken together, our findings point to the recruitment of 3 coordinated pathways that control the amount of fatty acids that are available for the fetus in response to GDM (ie, their rate of uptake from maternal circulation, the esterification/storage capacity, and the mobilizing activity for export).
In addition to lipid genes, our cluster analysis has highlighted that changes in pathways of glycogen turnover were enhanced in GDM, whereas pathways for glycosylation and acylation were recruited exclusively in T1DM. The upregulation of glycogen (the glycogen-branching enzyme GBE1) and of amylo1-6 glucosidase AGL are molecular markers for the acceleration of glucose fluxes into glycogen, which is a well-documented feature of diabetic pregnancy in humans and rodents. [36] [37] [38] [39] [40] The lack of glucose-6-phosphatase and the collocalization of glycogen and glycogen in endothelial cells lining the fetal circulation were key observations for the concept that it is the excess glucose from the fetus rather than from the mother that may be stored as glycogen. 41, 42 The increased expression of 10 genes for glycosylation and acylation reactions in T1DM suggested that hexosamine pathways may be recruited when tissue glycogen storage 
In vitro regulation of lipid accumulation in primary placental cells
The left side is a visualization of lipid droplets in primary term placental cells. Freshly isolated trophoblast cells were cultured for 48 hours with no addition (control) or the addition of glucose (10 mmol/L), oleate (400 nmol/L), or the combination of both. The right side shows the quantification of lipid accumulation by scanning densitometry. Results are given as mean Ϯ SE of 4-6 independent experiments with duplicate culture wells. The asterisk denotes a probability value of Ͻ .0001. 
FIGURE 6
Changes in placental pathways for glycogen turnover in pregnancy with gestational diabetes mellitus Glycogen initiates glycogen synthesis by attaching C-1 of a UDP-glucose to a tyrosine residue on the enzyme. The attached glucose serves as the primer, which is required by glycogen synthase to attach additional glucose molecules. The expression of glycogen synthase (GS) or glycogen phosphorylase (GP) was not modified in diabetes mellitus. capacities are exceeded. 43 GLUT10, which is a facilitative glucose transporter candidate gene for type 2 diabetes mellitus, 44 was the only gene that was related to glucose transfer to be upregulated in our dataset.
Taken together, these data point to a pronounced modification of fetoplacental lipid pathways and selective activation of transplacental lipid fluxes in pregnancy with GDM and obesity. Our findings have potential clinical implication in highlighting the importance of alterations of lipid homeostasis, besides glucose changes, as contributors to fetal macrosomia. 
